Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
646 |
|
| Actual shortage: | 62 (10%) | |
| Anticipated shortage: | 11 (2%) | |
| Avoided shortage: | 16 (2%) | |
| Resolved: | 557 (86%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
20 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OLANZAPINE | 7.5MG | TABLET | Resolved | 2025-08-11 | 2025-08-30 | 265010 |
| OLANZAPINE | 10MG | TABLET | Resolved | 2025-09-03 | 2025-11-27 | 266490 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-06-06 | 2018-09-28 | 12095 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-09-28 | 21989 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-11-16 | 21992 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-27 | 2018-12-11 | 30725 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2022-08-30 | 79597 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2024-03-02 | 79600 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-01-14 | 2024-02-27 | 103271 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-04-10 | 2024-05-22 | 224800 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Avoided shortage | 2024-07-03 | 2024-07-15 | 232029 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-11-25 | 2025-03-05 | 243713 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-04-07 | 2025-05-16 | 254376 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-07-31 | 2023-09-25 | 200456 |
| OLMESARTAN | 20MG | TABLET | Resolved | 2023-07-31 | 2024-01-17 | 200465 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-10-23 | 2024-02-12 | 207885 |
| OLMESARTAN | 20MG | TABLET | Resolved | 2024-03-11 | 2024-05-29 | 221869 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2024-03-11 | 2024-05-29 | 221872 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2025-09-03 | 2025-11-27 | 266468 |
| OLMESARTAN/HCTZ | 40MG 25MG | TABLET | Actual shortage | 2024-03-26 | 2024-12-02 | 223370 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3026 |
| RAMIPRIL-HCTZ | 12.5MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3029 |
| RAMIPRIL-HCTZ | 25.0MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3032 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| ROPINIROLE | 5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4945 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| SOLIFENACIN | 10MG | TABLET | Reversed | 2024-07-24 | 2025-01-13 | 233602 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| TRAMADOL/ACET | 325MG 37.5MG | TABLET | Discontinued | 2020-04-08 | 2020-07-07 | 111524 |